The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Liquid biopsies: Potential and challenges
Open accessAbstract
The analysis of tumor cells or tumor cell products obtained from blood or other body fluids (“liquid biopsy” [LB]) provides a broad range of opportunities in the field of oncology. Clinical application areas include early detection of cancer or tumor recurrence, individual risk assessment and therapy monitoring. LB allows to portray the entire disease as tumor cells or tumor cell products are released from all metastatic or primary tumor sites, providing comprehensive and real‐time information on tumor cell evolution, therapeutic targets and mechanisms of resistance to therapy. Here, we focus on the most prominent LB markers, circulating tumor cells (CTCs) and circulating tumor‐derived DNA (ctDNA), in the blood of patients with breast, prostate, lung and colorectal cancer, as the four most frequent tumor types in Europe. After a brief introduction of key technologies used to detect CTCs and ctDNA, we discuss recent clinical studies on these biomarkers for early detection and prognostication of cancer as well as prediction and monitoring of cancer therapies. We also point out current methodological and biological limitations that still hamper the implementation of LB into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 1×
“often present in different organs at the same time and have one strong, partly organ-dependent heterogeneity.(1,3,4) This diagnostic dilemma led to the development of the “liquid biopsy” (LB) concept.”
BackgroundEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492
Genome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1272-6 · Cited by 1,476
Neutrophils escort circulating tumour cells to enable cell cycle progression
Szczerba, B. M., Castro-Giner, F., Vetter, M., Krol, I., Gkountela, S., Landin, J., Scheidmann, M. C., Donato, C., Scherrer, R., Singer, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0915-y · Cited by 1,225
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110
Self-citationClonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082
Moss, J., Magenheim, J., Neiman, D., Zemmour, H., Loyfer, N., Korach, A., Samet, Y., Maoz, M., Druid, H., Arner, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07466-6 · Cited by 1,012
Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
Krebs, M. G., Sloane, R., Priest, L., Lancashire, L., Hou, J.-M., Greystoke, A., Ward, T. H., Ferraldeschi, R., Hughes, A., Clack, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7045 · Cited by 868
Hou, J.-M., Krebs, M. G., Lancashire, L., Sloane, R., Backen, A., Swain, R. K., Priest, L. J. C., Greystoke, A., Zhou, C., Morris, K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3716 · Cited by 842
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Circulating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Self-citationCirculating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding
Gkountela, S., Castro-Giner, F., Szczerba, B. M., Vetter, M., Landin, J., Scherrer, R., Krol, I., Scheidmann, M. C., Beisel, C., Stirnimann, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.046 · Cited by 801
Osmani, L., Askin, F., Gabrielson, E., & Li, Q. K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.019 · Cited by 773
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E., Shen, R., Abida, W., Juluru, K., De Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 769
Scher, H. I., Lu, D., Schreiber, N. A., Louw, J., Graf, R. P., Vargas, H. A., Johnson, A., Jendrisak, A., Bambury, R., Danila, D., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1828 · Cited by 641
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Self-citationSchiavon, G., Hrebien, S., Garcia-Murillas, I., Cutts, R. J., Pearson, A., Tarazona, N., Fenwick, K., Kozarewa, I., Lopez-Knowles, E., Ribas, R., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac7551 · Cited by 575
The emerging role of cell-free DNA as a molecular marker for cancer management
Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Chen, M., & Zhao, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0220-8 · Cited by 556
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Keller, L., & Pantel, K. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0180-2 · Cited by 544
Self-citationAnnala, M., Vandekerkhove, G., Khalaf, D., Taavitsainen, S., Beja, K., Warner, E. W., Sunderland, K., Kollmannsberger, C., Eigl, B. J., Finch, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0937 · Cited by 515
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Coombes, R. C., Page, K., Salari, R., Hastings, R. K., Armstrong, A., Ahmed, S., Ali, S., Cleator, S., Kenny, L., Stebbing, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3663 · Cited by 510
Heitzer, E., Auer, M., Gasch, C., Pichler, M., Ulz, P., Hoffmann, E. M., Lax, S., Waldispuehl-Geigl, J., Mauermann, O., Lackner, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4140 · Cited by 497
Self-citationMurtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Self-citationClinical utility of circulating non-coding RNAs — an update
Anfossi, S., Babayan, A., Pantel, K., & Calin, G. A. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0035-x · Cited by 450
Self-citationDETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES
Bettegowda, C., Sausen, M., Leary, R., Kinde, I., Agrawal, N., Bartlett, B., Wang, H., Luber, B., Kinzler, K., Vogelstein, B., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou206.24 · Cited by 441
Luo, H., Zhao, Q., Wei, W., Zheng, L., Yi, S., Li, G., Wang, W., Sheng, H., Pu, H., Mo, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7533 · Cited by 437
O’Leary, B., Hrebien, S., Morden, J. P., Beaney, M., Fribbens, C., Huang, X., Liu, Y., Bartlett, C. H., Koehler, M., Cristofanilli, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03215-x · Cited by 414
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Wyatt, A. W., Annala, M., Aggarwal, R., Beja, K., Feng, F., Youngren, J., Foye, A., Lloyd, P., Nykter, M., Beer, T. M., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx118 · Cited by 412
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Elazezy, M., & Joosse, S. A. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.002 · Cited by 370
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis
Ebright, R. Y., Lee, S., Wittner, B. S., Niederhoffer, K. L., Nicholson, B. T., Bardia, A., Truesdell, S., Wiley, D. F., Wesley, B., Li, S., et al. (2020) · Science · doi:10.1126/science.aay0939 · Cited by 365
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
Janni, W. J., Rack, B., Terstappen, L. W. M. M., Pierga, J.-Y., Taran, F.-A., Fehm, T., Hall, C., de Groot, M. R., Bidard, F.-C., Friedl, T. W. P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1603 · Cited by 363
Self-citationClinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Schøler, L. V., Reinert, T., Ørntoft, M.-B. W., Kassentoft, C. G., Árnadóttir, S. S., Vang, S., Nordentoft, I., Knudsen, M., Lamy, P., Andreasen, D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0510 · Cited by 306
ESR1 mutations in breast cancer
Dustin, D., Gu, G., & Fuqua, S. A. W. (2019) · Cancer · doi:10.1002/cncr.32345 · Cited by 306
Li, Y. S., Jiang, B. Y., Yang, J. J., Zhang, X. C., Zhang, Z., Ye, J. Y., Zhong, W. Z., Tu, H. Y., Chen, H. J., Wang, Z., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy009 · Cited by 300
Best, M. G., Wesseling, P., & Wurdinger, T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0887 · Cited by 297
Nicolazzo, C., Raimondi, C., Mancini, M., Caponnetto, S., Gradilone, A., Gandini, O., Mastromartino, M., del Bene, G., Prete, A., Longo, F., et al. (2016) · Scientific Reports · doi:10.1038/srep31726 · Cited by 281
Iinuma, H., Watanabe, T., Mimori, K., Adachi, M., Hayashi, N., Tamura, J., Matsuda, K., Fukushima, R., Okinaga, K., Sasako, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5151 · Cited by 279
Bidard, F.-C., Michiels, S., Riethdorf, S., Mueller, V., Esserman, L. J., Lucci, A., Naume, B., Horiguchi, J., Gisbert-Criado, R., Sleijfer, S., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy018 · Cited by 277
Self-citationCristofanilli, M., Pierga, J.-Y., Reuben, J., Rademaker, A., Davis, A. A., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., et al. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.004 · Cited by 274
Self-citationErratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm0715-827b · Cited by 255
Garlan, F., Laurent-Puig, P., Sefrioui, D., Siauve, N., Didelot, A., Sarafan-Vasseur, N., Michel, P., Perkins, G., Mulot, C., Blons, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3155 · Cited by 250
Yokobori, T., Iinuma, H., Shimamura, T., Imoto, S., Sugimachi, K., Ishii, H., Iwatsuki, M., Ota, D., Ohkuma, M., Iwaya, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0326 · Cited by 249
Self-citationGuibert, N., Delaunay, M., Lusque, A., Boubekeur, N., Rouquette, I., Clermont, E., Mourlanette, J., Gouin, S., Dormoy, I., Favre, G., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.001 · Cited by 236
Gasch, C., Bauernhofer, T., Pichler, M., Langer-Freitag, S., Reeh, M., Seifert, A. M., Mauermann, O., Izbicki, J. R., Pantel, K., & Riethdorf, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.188557 · Cited by 227
Self-citationCheng, Y.-H., Chen, Y.-C., Lin, E., Brien, R., Jung, S., Chen, Y.-T., Lee, W., Hao, Z., Sahoo, S., Min Kang, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10122-2 · Cited by 227
Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
Denève, E., Riethdorf, S., Ramos, J., Nocca, D., Coffy, A., Daurès, J.-P., Maudelonde, T., Fabre, J.-M., Pantel, K., & Alix-Panabières, C. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.202846 · Cited by 226
Self-citationFabbri, F., Carloni, S., Zoli, W., Ulivi, P., Gallerani, G., Fici, P., Chiadini, E., Passardi, A., Frassineti, G. L., Ragazzini, A., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.015 · Cited by 223
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
Annala, M., Struss, W. J., Warner, E. W., Beja, K., Vandekerkhove, G., Wong, A., Khalaf, D., Seppälä, I.-L., So, A., Lo, G., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.02.023 · Cited by 218
Tol, J., Koopman, M., Miller, M. C., Tibbe, A., Cats, A., Creemers, G. J. M., Vos, A. H., Nagtegaal, I. D., Terstappen, L. W. M. M., & Punt, C. J. A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp463 · Cited by 216
Papadaki, M. A., Stoupis, G., Theodoropoulos, P. A., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0584 · Cited by 204
Sparano, J., O’Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W., & Miller, K. D. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2574 · Cited by 203
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
Hofman, P., Heeke, S., Alix-Panabières, C., & Pantel, K. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz196 · Cited by 200
Self-citationCirculating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
Bork, U., Rahbari, N. N., Schölch, S., Reissfelder, C., Kahlert, C., Büchler, M. W., Weitz, J., & Koch, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.88 · Cited by 196
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Medina Diaz, I., Nocon, A., Mehnert, D. H., Fredebohm, J., Diehl, F., & Holtrup, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166354 · Cited by 192
Weiss, G., Schlegel, A., Kottwitz, D., König, T., & Tetzner, R. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.123 · Cited by 188
Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
Fujita, K., Kume, H., Matsuzaki, K., Kawashima, A., Ujike, T., Nagahara, A., Uemura, M., Miyagawa, Y., Tomonaga, T., & Nonomura, N. (2017) · Scientific Reports · doi:10.1038/srep42961 · Cited by 175
Remon, J., Caramella, C., Jovelet, C., Lacroix, L., Lawson, A., Smalley, S., Howarth, K., Gale, D., Green, E., Plagnol, V., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx017 · Cited by 168
Lampignano, R., Neumann, M. H. D., Weber, S., Kloten, V., Herdean, A., Voss, T., Groelz, D., Babayan, A., Tibbesma, M., Schlumpberger, M., et al. (2020) · Clinical Chemistry · doi:10.1373/clinchem.2019.306837 · Cited by 162
Self-citationMao, X., Zhang, Z., Zheng, X., Xie, F., Duan, F., Jiang, L., Chuai, S., Han-Zhang, H., Han, B., & Sun, J. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.11.2235 · Cited by 160
Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
Lorente, D., Olmos, D., Mateo, J., Bianchini, D., Seed, G., Fleisher, M., Danila, D. C., Flohr, P., Crespo, M., Figueiredo, I., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.05.023 · Cited by 159
Sherwood, J. L., Corcoran, C., Brown, H. J., Sharpe, A. D., Musilová, M., & Kohlmann, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150197 · Cited by 155
Goodman, C. R., Seagle, B.-L. L., Friedl, T. W. P., Rack, B. K., Látó, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0163 · Cited by 150
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Pantel, K., Hille, C., & Scher, H. I. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.287102 · Cited by 149
Self-citationGorges, T. M., Kuske, A., Roeck, K., Mauermann, O., Müller, V., Peine, S., Verpoort, K., Novosadová, V., Kubista, M., Riethdorf, S., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.260299 · Cited by 147
Self-citationAlmodovar, K., Iams, W. T., Meador, C. B., Zhao, Z., York, S. J., Horn, L., Yan, Y., Hernandez, J., Chen, H., Shyr, Y., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.09.1951 · Cited by 145
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Trapp, E. K., Janni, W., Schindlbeck, C., Jückstöck, J., Andergassen, U., de Gregorio, A., Alunni‐Fabbroni, M., Tzschaschel, M. L. J., Polasik, A., Koch, J., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy152 · Cited by 145
Self-citationLaere, B. D., van Dam, P., Whitington, T., Mayrhofer, M., Diaz, E. H., den Eynden, G. V., Vandebroek, J., Del‐Favero, J., Laere, S. V., Dirix, L. Y., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.01.011 · Cited by 143
Janning, M., Kobus, F., Babayan, A., Wikman, H., Velthaus, J.-L., Bergmann, S., Schatz, S., Falk, M., Berger, L.-A., Böttcher, L.-M., et al. (2019) · Cancers · doi:10.3390/cancers11060835 · Cited by 143
Self-citationΠαναγοπούλου, Μ., Karaglani, M., Balgkouranidou, I., Biziota, E., Koukaki, T., Karamitrousis, E., Nena, E., Tsamardinos, I., Kolios, G. C., Lianidou, E. S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0660-y · Cited by 142
Mostert, B., Jiang, Y., Sieuwerts, A. M., Wang, H., Vries, J. B., Biermann, K., Kraan, J., Lalmahomed, Z. S., van Galen, A., de Weerd, V., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27987 · Cited by 133
Satelli, A., Batth, I., Brownlee, Z., Mitra, A., Zhou, S.-H., Noh, H., Rojas, C., Li, H.-M., Meng, Q. H., & Li, S.-L. (2017) · OncoTarget · doi:10.18632/oncotarget.17632 · Cited by 131
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
Kuske, A., Gorges, T. M., Tennstedt, P., Tiebel, A.-K., Pompe, R. S., Preißer, F., Prues, S., Mazel, M., Markou, A. N., Lianidou, E. S., et al. (2016) · Scientific Reports · doi:10.1038/srep39736 · Cited by 127
Self-citationScharpenseel, H., Hanssen, A., Loges, S., Mohme, M., Bernreuther, C., Peine, S., Lamszus, K., Goy, Y., Petersen, C., Westphal, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43678-6 · Cited by 124
Self-citationCharacterization of different CTC subpopulations in non-small cell lung cancer
Hanssen, A., Wagner, J., Gorges, T. M., Taenzer, A., Uzunoglu, F. G., Driemel, C., Stoecklein, N. H., Knoefel, W. T., Angenendt, S., Hauch, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28010 · Cited by 117
Self-citationRiethdorf, S., Müller, V., Loibl, S., Nekljudova, V., Weber, K., Huober, J., Fehm, T. N., Schrader, I., Hilfrich, J., Holms, F., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0255 · Cited by 116
Self-citationKwan, T. T., Bardia, A., Spring, L. M., Giobbie‐Hurder, A., Kalinich, M., Dubash, T. D., Sundaresan, T. K., Hong, X., LiCausi, J. A., Ho, U. K., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0432 · Cited by 114
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
Lambros, M. B. K., Seed, G., Sumanasuriya, S., Gil, V., Crespo, M., Fontes, M. S., Chandler, R., Mehra, N., Fowler, G., Ebbs, B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0862 · Cited by 109
Crosbie, P. A. J., Shah, R. D., Krysiak, P., Zhou, C., Morris, K. L., Tugwood, J. D., Booton, R., Blackhall, F. H., & Dive, C. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.017 · Cited by 108
Gorges, T. M., Riethdorf, S., von Ahsen, O., Nastały, P., Roeck, K., Boede, M. O., Peine, S., Kuske, A., Schmid, E., Kneip, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9004 · Cited by 106
Self-citationMicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells
Anfossi, S., Fu, X., Nagvekar, R., & Călin, G. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_6 · Cited by 103
Mayo‐de‐las‐Casas, C., Jordana‐Ariza, N., Garzón‐Ibáñez, M., Balada‐Bel, A., Bertrán-Alamillo, J., Viteri, S., Reguart, N., Muñoz-Quintana, M. A., Barragán, P. L., Camps, C., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx288 · Cited by 99
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
Vendrell, J. A., Mau‐Them, F. T., Béganton, B., Godreuil, S., Coopman, P. J., & Solassol, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020264 · Cited by 98
Soler, A., Cayrefourcq, L., Mazard, T., Babayan, A., Lamy, P., Assou, S., Assénat, E., Pantel, K., & Alix‐Panabières, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34365-z · Cited by 92
Self-citationMa, F., Guan, Y., Yi, Z., Chang, L., Li, Q., Chen, S., Zhu, W., Guan, X., Li, C., Qian, H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32536 · Cited by 90
Epithelial keratins: Biology and implications as diagnostic markers for liquid biopsies
Werner, S., Keller, L., & Pantel, K. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.001 · Cited by 89
Self-citationTsui, D. W. Y., Murtaza, M., Wong, A. S. C., Rueda, O. M., Smith, C. G., Chandrananda, D., Soo, R. A., Lim, H. L., Goh, B. C., Caldas, C., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201707945 · Cited by 86
Markou, A. N., Lazaridou, M., Paraskevopoulos, P., Chen, S., Świerczewska, M., Budna, J., Kuske, A., Gorges, T. M., Joosse, S. A., Kroneis, T., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.275503 · Cited by 82
Self-citationCompartmental Differences of Circulating Tumor Cells in Colorectal Cancer
Rahbari, N. N., Bork, U., Kircher, A., Nimitz, T., Schölch, S., Kahlert, C., Schmidt, T., Steinert, G., Ulrich, A. B., Reißfelder, C., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2178-1 · Cited by 80
Heliebi, A. E., Hille, C., Laxman, N., Svedlund, J., Haudum, C. W., Ercan, E., Kroneis, T., Chen, S., Smolle, M. A., Rossmann, C. H., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.281295 · Cited by 80
Self-citationMetabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
Chen, J., Cao, S., Situ, B., Zhong, J., Hu, Y., Li, S., Huang, J., Xu, J., Wu, S., Lin, J., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0789-0 · Cited by 78
Lu, C.-Y., Tsai, H.-L., Uen, Y.-H., Hu, H., Chen, C.-W., Cheng, T.-L., Lin, S., & Wang, J.-Y. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.595 · Cited by 77
Boffa, D. J., Graf, R. P., Salazar, M. C., Hoag, J. R., Lu, D. M., Krupa, R., Louw, J. E., Dugan, L., Wang, Y., Landers, M. A., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0120 · Cited by 70
McDaniel, A. S., Ferraldeschi, R., Krupa, R., Landers, M. A., Graf, R. P., Louw, J. E., Jendrisak, A., Bales, N., Marrinucci, D. C., Zafeiriou, Z., et al. (2016) · British Journal of Urology · doi:10.1111/bju.13631 · Cited by 68
Zhang, X., Zhao, W., Wei, W., You, Z., Ou, X., Sun, M., Yin, Y., Tang, X., Zhao, Z., Hu, C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4055 · Cited by 68
Single tube liquid biopsy for advanced non‐small cell lung cancer
de Wit, S., Rossi, E. M. C., Weber, S., Tamminga, M., Manicone, M., Swennenhuis, J. F., Groothuis‐Oudshoorn, C. G. M., Vidotto, R., Facchinetti, A., Zeune, L. L., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32056 · Cited by 64
Suhaimi, N.-A. M., Foong, Y. M., Lee, D. Y. S., Phyo, W. M., Cima, I., Lee, E. X. W., Goh, W. L., Lim, W.-Y., Chia, K. S., Kong, S. L., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.011 · Cited by 63
Haldrup, C., Pedersen, A. L., Øgaard, N., Strand, S. H., Høyer, S., Borre, M., Orntoft, T. F., & Sørensen, K. D. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12183 · Cited by 63
Ng, S. B. H., Chua, C., Ng, M. C. H., Gan, A., Poon, P. S. Y., Teo, M. C. C., Fu, C. W. P., Leow, W. Q., Lim, K. H., Chung, A. Y. F., et al. (2017) · Scientific Reports · doi:10.1038/srep40737 · Cited by 61
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC
Buder, A., Hochmair, M. J., Schwab, S., Bundalo, T., Schenk, P., Errhalt, P., Mikes, R. E., Absenger, G., Patocka, K., Baumgartner, B., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.02.014 · Cited by 60
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
O’Reilly, E., Tuzova, A. V., Walsh, A. L., Russell, N. M., O’Brien, O., Kelly, S., Dhomhnalláin, O. N., DeBarra, L., Dale, C. M., Brugman, R., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00134 · Cited by 56
Strati, A. D., Nikolaou, M., Georgoulias, V., & Lianidou, E. S. (2019) · Cells · doi:10.3390/cells8070652 · Cited by 56
Hanssen, A., Riebensahm, C., Mohme, M., Joosse, S. A., Velthaus, J.-L., Berger, L. A., Bernreuther, C., Glatzel, M., Loges, S., Lamszus, K., et al. (2018) · Cancers · doi:10.3390/cancers10120527 · Cited by 54
Self-citationGenomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance
Du, M., Thompson, J., Fisher, H., Zhang, P., Huang, C., & Wang, L. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.008 · Cited by 51
Gao, C., Xiao, G., Piersigilli, A., Gou, J., Ogunwobi, O. O., & Bargonetti, J. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1094-8 · Cited by 49
Disseminated breast tumour cells: biological and clinical meaning
Pantel, K., & Hayes, D. F. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.174 · Cited by 47
Self-citationVivancos, A. P., Aranda, E., Benavides, M., Élez, E., Gómez‐España, M. A., Toledano‐Fonseca, M., Álvarez, M., Chica-Parrado, M. D. R., García‐Barberán, V., & Díaz‐Rubio, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-45616-y · Cited by 47
Kalikaki, A., Politaki, H., Souglakos, J., Apostolaki, S., Papadimitraki, E., Georgoulia, N., Tzardi, M. N., Mavroudis, D., Georgoulias, V., & Voutsina, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104902 · Cited by 46
Magbanua, M. J. M., Rugo, H. S., Wolf, D. M., Hauranieh, L., Roy, R., Pendyala, P., Sosa, E. V., Scott, J. H., Lee, J. S., Pitcher, B. N., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2312 · Cited by 45
Geva, S., Rozenblum, A. B., Twito, T., Grinberg, R., Dvir, A., Soussan‐Gutman, L., Ilouze, M., Roisman, L. C., Dudnik, E., Zer, A., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.07.101 · Cited by 44
EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay
Soler, A., Cayrefourcq, L., Mazel, M., & Alix‐Panabières, C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7144-2_22 · Cited by 43
D’Orsi, C. J., Getty, D. J., Pickett, R. M., et al. (2012) · Radiology · doi:10.1148/radiol.12120382 · Cited by 40
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature
Singhal, U., Wang, Y., Henderson, J., Niknafs, Y. S., Qiao, Y., Gursky, A. M., Zaslavsky, A., Chung, J., Smith, D. C., Karnes, R. J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0539 · Cited by 37
Yang, M., Topaloĝlu, Ü., Petty, W. J., Pagni, M., Foley, K. L., Grant, S. C., Robinson, M., Bitting, R. L., Thomas, A., Alistar, A. T., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0468-1 · Cited by 36
Matsusaka, S., Suenaga, M., Mishima, Y., Takagi, K., Terui, Y., Mizunuma, N., & Hatake, K. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1543-2 · Cited by 34
Budna, J., Świerczewska, M., Mazel, M., Cieślikowski, W. A., Ida, A., Jankowiak, A., Antczak, A., Nowicki, M. O., Pantel, K., Azria, D., et al. (2019) · Cancers · doi:10.3390/cancers11060802 · Cited by 32
Self-citationJoosse, S. A., Beyer, B., Gasch, C., Nastały, P., Kuske, A., Isbarn, H., Horst, L. J., Hille, C., Gorges, T. M., Cayrefourcq, L., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.310912 · Cited by 30
Self-citationDeciphering cancer clues from blood
Ma, N., & Jeffrey, S. S. (2020) · Science · doi:10.1126/science.abb0736 · Cited by 30
Cleris, L., Daidone, M. G., Fina, E., & Cappelletti, V. (2019) · Cells · doi:10.3390/cells8070683 · Cited by 28
León‐Mateos, L., Casas, H., Abalo, A., Vieito, M., Abreu, M., Anido, U., Gómez‐Tato, A., López‐López, R., Abal, M., & Muinelo‐Romay, L. (2017) · Oncotarget · doi:10.18632/oncotarget.18025 · Cited by 25
Berger, L.-A., Janning, M., Velthaus, J.-L., Batalla, I. B., Schatz, S., Falk, M., Iglauer, P., Simon, R., Cao, R., Forcato, C., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.08.2025 · Cited by 23
Self-citationAn expanded biomarker panel for the detection of prostate cancer from urine DNA
Brikun, I. A., Nusskern, D. R., & Freije, D. (2019) · Experimental Hematology and Oncology · doi:10.1186/s40164-019-0137-x · Cited by 22
Hench, I. B., Cathomas, R. L., Costa, L., Fischer, N., Gillessen, S., Hench, J., Hermanns, T., Kremer, E. A., Mingrone, W. B., Mestre, R. P., et al. (2019) · Cancers · doi:10.3390/cancers11081099 · Cited by 22
Evolution of the Liquid Biopsy in Metastatic Prostate Cancer
Moreno, J. G., & Gomella, L. G. (2019) · Urology · doi:10.1016/j.urology.2019.06.006 · Cited by 13
Cited by
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Lone, S. N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S., El-Rifai, W., Bedognetti, D., Batra, S. K., Haris, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01543-7 · Cited by 819
Rolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., Bivona, T., Diehn, M., Dive, C., Dziadziuszko, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.017 · Cited by 683
Molecular Biomarkers in Cancer
Sarhadi, V. K., & Armengol, G. (2022) · Biomolecules · doi:10.3390/biom12081021 · Cited by 467
Zhou, H., Zhu, L., Song, J., Wang, G., Li, P., Li, W., Luo, P., Sun, X., Wu, J., Liu, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01556-2 · Cited by 261
Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stütz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bäuerle, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1324 · Cited by 39
Metadata
- Authors
- Heidrich, I., Ačkar, L., Mossahebi Mohammadi, P., & Pantel, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2020-08-10
- Volume
- 148
- Issue
- 3
- Pages
- 528-545
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W3045385411
- Cited by
- 278
- References
- 132
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.